LIM
NXTM

Longfellow Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Longfellow Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,500
Closed -$373K – 95
2017
Q3 		$373K Buy
+13,500
New +$360K 0.1% 64

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Longfellow Investment Management's NXTM Position: Q4 2017 in Review

Longfellow Investment Management sold out of NxStage Medical Inc. (NXTM) in Q4 2017, closing a stake of 13,500 shares — an estimated $373K sold.

Longfellow Investment Management first reported a position in NXTM in Q3 2017 and held it in 1 quarter. The position peaked at $373K in Q3 2017. 178 funds tracked by Wall St. Rank hold NXTM as of Q4 2017.

  • Longfellow Investment Management reported no remaining NxStage Medical Inc. position as of Q4 2017 after selling out during the quarter.
  • Longfellow Investment Management sold 13,500 NxStage Medical Inc. shares in Q4 2017, an estimated $373K.
  • Longfellow Investment Management first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 1 quarter.
  • Longfellow Investment Management's NxStage Medical Inc. position peaked at $373K in Q3 2017.
  • 178 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2017.

Based on Longfellow Investment Management's 13F filing for Q4 2017, filed 19 Jan 2018.